Showing results (51-60 of 316) with videos related to

Sort By:
Pageof 32
Fertility and Sterility|February 13, 2017
Deceased donor uterine transplantationRebecca Flyckt, Alexander Kotlyar, Sara Arian, et al.
Oncology (Williston Park, N.Y.)|February 4, 2010
Adjuvant treatment after orthotopic liver transplantation: is it really necessary?Richard Kim, Ann Tan, Bassam Estfan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2004
Liver transplantation in patients with HIV infectionJohn Fung, Bijan Eghtesad, Kusum Patel-Tom, et al.
World Journal of Gastroenterology|May 17, 2014
Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand?Masato Fujiki, Federico Aucejo, Minsig Choi, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 21, 2005
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver diseaseMargaret V Ragni, Bijan Eghtesad, Kimberly W Schlesinger, et al.
Surgery|January 23, 2022
Transplantation of declined livers after normothermic perfusionCristiano Quintini, Luca Del Prete, Andrea Simioni, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 26, 2005
Liver transplantation for severe intrahepatic noncirrhotic portal hypertensionAlyssa M Krasinskas, Bijan Eghtesad, Patrick S Kamath, et al.
Transplantation|October 8, 2005
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantationAshokkumar Jain, Raman Vekatramanan, Bijan Eghtesad, et al.
The American Journal of Surgical Pathology|October 26, 2006
Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathySusan C Abraham, Patrick S Kamath, Bijan Eghtesad, et al.
Oncology (Williston Park, N.Y.)|May 10, 2011
What is the indication for sorafenib in hepatocellular carcinoma? A clinical challengeRichard Kim, Michael T Byrne, Ann Tan, et al.
Pageof 32